FIELD: medicine.
SUBSTANCE: method involves studying blood plasma chemoluminescence intensity and nitrogen oxide derivatives content. Total percent of changes of said indices relative to reference value is calculated. The change being insignificant like reduction from -21.7% to -148%, single cerebral metastasis is diagnosed. The value growing from 200% to 1000%, multiple metastatic brain injury independent of primary tumor lesion focus localization is diagnosed.
EFFECT: high prognosis accuracy.
1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DETERMINING PATHOLOGICAL PROCESS GENERALIZATION IN THE CASES OF ONCOLOGICAL DISEASES | 2002 |
|
RU2241987C2 |
| METHOD FOR DETERMINATION OF MALIGNANT PROCESS ABUNDANCE | 2005 |
|
RU2289815C1 |
| PROGNOSIS OF TREATMENT EFFECTIVENESS FOR III-IV-STEP BREAST CANCER PATIENTS | 2003 |
|
RU2254576C2 |
| METHOD FOR PREDICTING CEREBRAL METASTASIS LESION FOCI IN METASTATIC BRAIN INJURY PATIENTS | 2005 |
|
RU2300109C2 |
| METHOD OF FORECASTING OF AUTOHEMOCHEMIOTHERAPY EFFICIENCY AT PATIENTS WITH RELAPSES AND METASTASISES OF UTERUS NECK CANCER | 2007 |
|
RU2352942C1 |
| METHOD FOR TREATING ONCOLOGICAL PATIENTS WITH METASTATIC CEREBRAL LESION | 2005 |
|
RU2290974C1 |
| METHOD FOR PREDICTING EXTRACRANIAL METASTASES DEVELOPMENT IN PATIENTS HAVING METASTASES IN BRAIN | 2005 |
|
RU2297005C1 |
| METHOD FOR TREATING CEREBRAL METASTASES OF GENERALIZED SKIN MELANOMA | 2005 |
|
RU2286146C1 |
| METHOD FOR DETECTING EXTRACRANIAL METASTASES IN METASTATIC BRAIN INJURY PATIENTS | 2005 |
|
RU2300110C2 |
| METHOD FOR ASSAY OF TREATMENT EFFICACY OF PATIENTS WITH INTRACEREBRAL MALIGNANT TUMORS | 2003 |
|
RU2255745C2 |
